Image

AIR (Artificial Implant to Restore the Medial Meniscus Function)2 Clinical Investigation

AIR (Artificial Implant to Restore the Medial Meniscus Function)2 Clinical Investigation

Non Recruiting
18-70 years
All
Phase N/A

Powered by AI

Overview

The AIR2 Study is a multi-center, prospective, interventional clinical trial with the objective to evaluate the safety and performance of the Trammpolin® medial meniscus prosthesis.

Description

The Trammpolin® meniscus prosthesis is intended to replace the native medial meniscus to provide pain relief in the medial compartment of the knee joint, when this is caused by medial partial meniscectomy.

Patients who meet the inclusion/exclusion criteria and who are implanted with the Trammpolin® medial meniscus prosthesis will be followed for 2 years. The patient reported outcome measures for knee pain and function, and knee clinical condition by MRI and X-ray is assessed post-operative compared to pre-operative.

Eligibility

Inclusion Criteria:

  1. Has medial compartment knee pain and had a medial partial or total meniscectomy > 6 months ago. The lack of meniscus tissue is confirmed by patient history and MRI
  2. Has a KOOS Pain of ≤ 75 (100 being no pain and the highest attainable score)
  3. Is between age 18 and 70 years (inclusive) at the time of screening
  4. Has neutral alignment ± 5° of the mechanical axis, i.e., the angle formed by a line drawn from the center of the femoral head to the medial tibial spine and a line drawn from the medial tibial spine to the center of the ankle joint, as confirmed by X-ray
  5. Is willing to be implanted with the Trammpolin® medial meniscus prosthesis
  6. Is willing and able to comply to the clinical investigation required follow up visits, questionnaires, X-rays and MRI's
  7. Is able and willing to understand and sign the clinical investigation Informed Consent Form
  8. Is able to read and understand the national language of the country in which the relevant clinical site is located

Exclusion Criteria:

  1. Has a symptomatic knee because of a tear that could potentially be addressed by a repeat partial meniscectomy
  2. Has evidence of a modified Outerbridge Grade IV cartilage loss on the medial tibial plateau or femoral condyle that potentially could contact a Trammpolin® medial meniscus prosthesis
  3. Has lateral compartment pain and Grade III or Grade IV modified Outerbridge cartilage score in the lateral compartment
  4. Has a varus or valgus knee deformity of > 5° requiring a tibial or femoral osteotomy
  5. Has a varus alignment that is not passively correctable
  6. Has a laxity level of more than Grade II (IKDC), primary or secondary to an injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL)
  7. Has significant trochlear dysplasia, patellar instability or symptomatic patellar misalignment
  8. Has patellar compartment pain and Grade III or Grade IV modified Outerbridge cartilage score in the patellar compartment.
  9. Compared to a normal knee, has obvious radiological evidence of medial femoral squaring, anatomical variance in the medial tibial plateau, or irregularly shaped cartilage surface
  10. Had an ACL reconstruction performed < 9 months prior to surgery
  11. Has a BMI > 30 at the time of screening
  12. Has a knee flexion contracture > 10°
  13. Has a knee flexion < 90°
  14. Had a previous High Tibial Osteotomy (HTO) < 1 year ago
  15. Has insufficiency fractures or avascular necrosis of the medial compartment
  16. Has an active infection or tumor (local or systemic)
  17. Has any type of knee joint inflammatory disease including Sjogren's syndrome
  18. Has neuropathic knee osteoarthropathy, also known as Charcot joint
  19. Has any medical condition that does not allow possible arthroscopy of the knee
  20. Has neurological deficit (sensory, motor, or reflex)
  21. Is currently involved in another investigation of the lower extremity
  22. Anticipates having another lower extremity surgery during the clinical investigation period
  23. Has received any corticosteroid knee injections ≤ 3 months prior to surgery
  24. Has proven osteoporosis
  25. Is on immunostimulating or immunosuppressing agents
  26. Has ipsilateral or contralateral lower limb joint conditions that may affect ambulation or KOOS (e.g. have a leg length discrepancy > 2.5 cm [1 inch], causing a noticeable limp)
  27. Is a female who is lactating, expecting, or is intending to become pregnant during the clinical investigation period
  28. Is mentally incapacitated (incapable of appraising or controlling conduct) or have mental disability (e.g., dementia or Alzheimer's)
  29. Has a condition or be in a situation that, in the Investigator's opinion, may confound the clinical investigation results, may risk the safety of the patient, or may interfere significantly with the subject's participation in the clinical investigation

Study details
    Knee Injuries and Disorders

NCT05297175

ATRO Medical B.V.

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.